Back to all studies
RecruitingNCT07478796

TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children

This study is recruiting. It focuses on depression and currently lists participation information in Poland.

DepressionOtherOver 12 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT07478796. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This study is looking at whether a digital support tool can help people with Depression - depression or Depressive Episodes. Participants receive a study treatment and complete follow-up visits and assessments. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a university, with sites including Szpital Kliniczny im Karola Jonschera UMP (Poznan University of Medical Sciences). Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually matching the main diagnosis and being able to understand the study and consent, while common reasons not to take part include pregnancy or breastfeeding and other factors that could make participation unsuitable. This is a later-stage study, which usually means the approach is being followed in broader real-world use.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateStarted: April 3, 2025
Recruitment status
Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Poznan University of Medical Sciences
Sponsor type
University
Study type
Other
Intervention type
Device / app / digital / technology
Study phase
Not clearly listed
Locations
Poland
Age range
Over 12 Years
Official registry ID
NCT07478796
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT07478796. We help you review the study, but cannot decide medical eligibility.
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may help clarify how this condition is measured or understood.

It requires regular visits and structured follow-up.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a device, app, or technology?

This appears to be a device / app / digital / technology study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with depression; age range: Over 12 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to use a device, app, or digital tool for a defined period. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What should I check about data, monitoring, alerts, and daily use?

If the study uses a device, app, or digital tool, check what data is collected, who can access it, how often you need to use it, and what happens if the tool detects a concerning signal. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Poznan University of Medical Sciences, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study is currently recruiting. This does not mean you are eligible: the study team must confirm the criteria, available locations, and next steps.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
TDM-Guided Treatment With SSRIs in Hospitalized Adults and Children — Depression Clinical Trial | HopeStage